|
Synonyms: compound 1 [WO2020024977] | MT-200605
Compound class:
Synthetic organic
Comment: MT200605 is a small-molecule tropomyosin receptor kinase B (TrkB; NTRK2) agonist [2], that mimics the effect of endogenous agonist (brain-derived neurotrophic factor, BDNF)-mediated receptor activation and downstream signalling [1]. This mechanism is proposed for neuroprotective action, to inhibit ischaemic-reperfusion injury following cerebral stroke.
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Li X, Zhang M, Wang B, Wu X, Li R, Wang R, Song L, Wang L, Yu Z, Dong R. (2026)
Preclinical and first-in-human phase I trial of MT200605: A novel TrkB agonist for acute ischaemic stroke. Br J Clin Pharmacol, [Epub ahead of print]. [PMID:42767275] |
|
2. Wang R, Ding W, Fu G. (2020)
Compound for treating nervous system diseases and use thereof. Patent number: WO2020024977A1. Assignee: Shaanxi Micot Technology Co Ltd. Priority date: 31/07/2019. Publication date: 06/02/2020. |